Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China
· Delayed Price · Currency is CNY 12.17
-0.11 (-0.90%)
Apr 29, 2026, 3:04 PM CST
SHE:000403 Revenue
Pacific Shuanglin Bio-pharmacy had revenue of 342.92M CNY in the quarter ending March 31, 2026, a decrease of -8.47%. This brings the company's revenue in the last twelve months to 2.60B, up 0.28% year-over-year. In the year 2025, Pacific Shuanglin Bio-pharmacy had annual revenue of 2.63B, down -0.83%.
Revenue (ttm)
2.60B
Revenue Growth
+0.28%
P/S Ratio
4.90
Revenue / Employee
904.20K
Employees
2,635
Market Cap
11.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.63B | -22.08M | -0.83% |
| Dec 31, 2024 | 2.65B | 325.96M | 14.00% |
| Dec 31, 2023 | 2.33B | -76.47M | -3.18% |
| Jan 1, 2023 | 2.41B | 433.45M | 21.98% |
| Jan 1, 2022 | 1.97B | 921.80M | 87.80% |
| Jan 1, 2021 | Pro | Pro | Pro |
| Jan 1, 2020 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 704.16M |
| Chongqing Genrix Biopharmaceutical | 230.72M |
| Vcanbio Cell & Gene Engineering Corp., | 1.42B |
| Hualan Biological Vaccine | 1.20B |
| Chengdu Easton Biopharmaceuticals | 1.35B |
| InventisBio | 37.29M |
| Tibet Cheezheng Tibetan Medicine | 2.42B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 15.90B |